Seeing Is Believing
Healthcare - Sector
ADPT is currently covered by 5 analysts with an average price target of $21.3. This is a potential upside of $6.25 (-5.63%) from yesterday's end of day stock price of $22.57.
Adaptive Biotechnologies Corp's activity chart (see below) currently has 95 price targets and 81 ratings on display. The stock rating distribution of ADPT is 76.47% BUY and 23.53% HOLD.
Analysts average stock forecasts to be materialized ratio is 82.67% with an average time for these price targets to be met of 262.57 days.
Highest price target for ADPT is $25, Lowest price target is $18, average price target is $21.3.
Most recent stock forecast was given by TEJAS SAVANT from MORGAN STANLEY on 30-Jul-2026. First documented stock forecast 13-Nov-2014.
Currently out of the existing stock ratings of ADPT, 13 are a BUY (76.47%), 4 are a HOLD (23.53%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Sep-2020
$22
$-0.57 (-2.53%)
$20
2 days ago
(30-Jul-2026)
12/18 (66.67%)
$-2.18 (-9.02%)
517
Buy Since 30-Sep-2025
$25
$2.43 (10.77%)
$22
2 days ago
(30-Jul-2026)
4/5 (80%)
$0.82 (3.39%)
67
Buy Since 07-Oct-2020
$25
$2.43 (10.77%)
$22
2 days ago
(30-Jul-2026)
15/20 (75%)
$0.82 (3.39%)
200
Buy Since 03-Aug-2023
$20
$-2.57 (-11.39%)
$10
8 months 26 days ago
(06-Nov-2025)
8/8 (100%)
$4.44 (28.53%)
204
Buy Since 21-Dec-2022
$20
$-2.57 (-11.39%)
$15
9 months 17 days ago
(15-Oct-2025)
14/14 (100%)
$2.89 (16.89%)
332
What is ADPT (Adaptive Biotechnologies Corp) average time for price targets to be met?
Which analyst has the current highest performing score on ADPT (Adaptive Biotechnologies Corp) with a proven track record?
Which analyst has the most public recommendations on ADPT (Adaptive Biotechnologies Corp)?
Which analyst is the currently most bullish on ADPT (Adaptive Biotechnologies Corp)?
Which analyst is the currently most reserved on ADPT (Adaptive Biotechnologies Corp)?